Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin

Adv Enzyme Regul. 2000:40:271-84. doi: 10.1016/s0065-2571(99)00026-6.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Cell Line, Transformed
  • Humans
  • Indomethacin / pharmacology*
  • Magnetic Resonance Spectroscopy
  • Neoplasm Invasiveness
  • Phospholipids / metabolism*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Phospholipids
  • Indomethacin